These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31714683)

  • 1. Deletion of the FHL2 gene attenuates intima-media thickening in a partially ligated carotid artery ligated mouse model.
    Chen CY; Tsai HY; Tsai SH; Chu PH; Huang PH; Chen JW; Lin SJ
    J Cell Mol Med; 2020 Jan; 24(1):160-173. PubMed ID: 31714683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LIM-only protein FHL2 attenuates inflammation in vascular smooth muscle cells through inhibition of the NFκB pathway.
    van de Pol V; Vos M; DeRuiter MC; Goumans MJ; de Vries CJM; Kurakula K
    Vascul Pharmacol; 2020; 125-126():106634. PubMed ID: 31866461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The LIM-only protein FHL2 reduces vascular lesion formation involving inhibition of proliferation and migration of smooth muscle cells.
    Kurakula K; Vos M; Otermin Rubio I; Marinković G; Buettner R; Heukamp LC; Stap J; de Waard V; van Tiel CM; de Vries CJ
    PLoS One; 2014; 9(4):e94931. PubMed ID: 24736599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortistatin inhibits migration and proliferation of human vascular smooth muscle cells and decreases neointimal formation on carotid artery ligation.
    Duran-Prado M; Morell M; Delgado-Maroto V; Castaño JP; Aneiros-Fernandez J; de Lecea L; Culler MD; Hernandez-Cortes P; O'Valle F; Delgado M
    Circ Res; 2013 May; 112(11):1444-55. PubMed ID: 23595952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of the FHL2 gene attenuates the formation of atherosclerotic lesions after a cholesterol-enriched diet.
    Chu PH; Yeh HI; Wu HH; Hong RC; Shiu TF; Yang CM
    Life Sci; 2010 Feb; 86(9-10):365-71. PubMed ID: 20096293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of four-and-a-half LIM domain protein-2 increases survival, migratory capacity, and paracrine function of human early outgrowth cells through activation of the sphingosine kinase-1 pathway: implications for endothelial regeneration.
    Ebrahimian T; Arfa O; Simeone S; Lemarié CA; Lehoux S; Wassmann S
    Circ Res; 2014 Jan; 114(1):114-23. PubMed ID: 24084691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deletion of Methionine Sulfoxide Reductase A Does Not Affect Atherothrombosis but Promotes Neointimal Hyperplasia and Extracellular Signal-Regulated Kinase 1/2 Signaling.
    Klutho PJ; Pennington SM; Scott JA; Wilson KM; Gu SX; Doddapattar P; Xie L; Venema AN; Zhu LJ; Chauhan AK; Lentz SR; Grumbach IM
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2594-604. PubMed ID: 26449752
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MFAP4 Promotes Vascular Smooth Muscle Migration, Proliferation and Accelerates Neointima Formation.
    Schlosser A; Pilecki B; Hemstra LE; Kejling K; Kristmannsdottir GB; Wulf-Johansson H; Moeller JB; Füchtbauer EM; Nielsen O; Kirketerp-Møller K; Dubey LK; Hansen PB; Stubbe J; Wrede C; Hegermann J; Ochs M; Rathkolb B; Schrewe A; Bekeredjian R; Wolf E; Gailus-Durner V; Fuchs H; Hrabě de Angelis M; Lindholt JS; Holmskov U; Sorensen GL
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):122-33. PubMed ID: 26564819
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The LIM-only protein FHL2 controls mesenchymal cell osteogenic differentiation and bone formation through Wnt5a and Wnt10b.
    Brun J; Fromigué O; Dieudonné FX; Marty C; Chen J; Dahan J; Wei Y; Marie PJ
    Bone; 2013 Mar; 53(1):6-12. PubMed ID: 23201222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fasudil, a Rho‑kinase inhibitor, prevents intima‑media thickening in a partially ligated carotid artery mouse model: Effects of fasudil in flow‑induced vascular remodeling.
    Zhang X; Zhang T; Gao F; Li Q; Shen C; Li Y; Li W; Zhang X
    Mol Med Rep; 2015 Nov; 12(5):7317-25. PubMed ID: 26458725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of Hyaluronan Synthase 3 Inhibits Neointimal Hyperplasia in Mice.
    Kiene LS; Homann S; Suvorava T; Rabausch B; Müller J; Kojda G; Kretschmer I; Twarock S; Dai G; Deenen R; Hartwig S; Lehr S; Köhrer K; Savani RC; Grandoch M; Fischer JW
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):e9-16. PubMed ID: 26586662
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The four-and-a-half LIM domain protein 2 regulates vascular smooth muscle phenotype and vascular tone.
    Neuman NA; Ma S; Schnitzler GR; Zhu Y; Lagna G; Hata A
    J Biol Chem; 2009 May; 284(19):13202-12. PubMed ID: 19265191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deletion of FHL2 gene impaired ischemia-induced blood flow recovery by modulating circulating proangiogenic cells.
    Huang PH; Chen CY; Lin CP; Wang CH; Tsai HY; Lo WY; Leu HB; Chen JW; Lin SJ; Chu PH
    Arterioscler Thromb Vasc Biol; 2013 Apr; 33(4):709-17. PubMed ID: 23413425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Four-and-a-half LIM domain protein 2 is a novel regulator of sphingosine 1-phosphate receptor 1 in CCL19-induced dendritic cell migration.
    König K; Diehl L; Rommerscheidt-Fuss U; Golletz C; Quast T; Kahl P; Kolanus W; Knolle P; Buettner R; Heukamp LC
    J Immunol; 2010 Aug; 185(3):1466-75. PubMed ID: 20592280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cathepsin S Activity Controls Injury-Related Vascular Repair in Mice via the TLR2-Mediated p38MAPK and PI3K-Akt/p-HDAC6 Signaling Pathway.
    Wu H; Cheng XW; Hu L; Takeshita K; Hu C; Du Q; Li X; Zhu E; Huang Z; Yisireyili M; Zhao G; Piao L; Inoue A; Jiang H; Lei Y; Zhang X; Liu S; Dai Q; Kuzuya M; Shi GP; Murohara T
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1549-57. PubMed ID: 27365406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombospondin-1 activates medial smooth muscle cells and triggers neointima formation upon mouse carotid artery ligation.
    Moura R; Tjwa M; Vandervoort P; Cludts K; Hoylaerts MF
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2163-9. PubMed ID: 17761938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LIM-Only Protein FHL2 Is a Negative Regulator of Transforming Growth Factor β1 Expression.
    Dahan J; Levillayer F; Xia T; Nouët Y; Werts C; Fanton d'Andon M; Adib-Conquy M; Cassard-Doulcier AM; Khanna V; Chen J; Tordjmann T; Buendia MA; Jouvion G; Wei Y
    Mol Cell Biol; 2017 May; 37(10):. PubMed ID: 28223370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of FHL2 in wound healing and inflammation.
    Wixler V
    FASEB J; 2019 Jul; 33(7):7799-7809. PubMed ID: 30939249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of FHL2 promotes tumorigenesis in cervical cancer and is correlated with poor prognosis.
    Jin X; Jiao X; Jiao J; Zhang T; Cui B
    Gene; 2018 Aug; 669():99-106. PubMed ID: 29800735
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Under-expression of α8 integrin aggravates experimental atherosclerosis.
    Menendez-Castro C; Cordasic N; Neureiter D; Amann K; Marek I; Volkert G; Stintzing S; Jahn A; Rascher W; Hilgers KF; Hartner A
    J Pathol; 2015 May; 236(1):5-16. PubMed ID: 25511181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.